bpc-157 pills vs injection FDA scientists flag concerns with peptides as RFK Jr. tries to ease access : NPR bpc-157 peptide pill vs injection

BPC-157 is studied for localized peptide signaling, while TB-500 is studied for actin-related and structural pathway behavior

Interaction with chelators avoid concurrent use of EDTA or other strong chelators, which may strip copper from the peptide complex and abolish activity

Each vial is sealed with a flip-top lid and supplied as a sterile, non-pyrogenic solution ready for immediate laboratory use

The fundamental difference: 5-Amino-1MQ acts upstream at the enzyme level

Animal studies report wide therapeutic windows

Three specific gaps separate this preclinical evidence from a human recommendation, and it is worth naming each so the framing throughout this guide is not mistaken for false modesty